Rapana, Jayshel L.

HRN: 29-29-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/10/2026
07/16/2026
IVT
1g
Q6H
Dengue Shock Syndrome; ARTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines